Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K K Fu

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Cancer|June 1, 1992
Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol 8313J D Cox, T F Pajak, V A Marcial, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1994
Carcinomas of the oropharynx treated with hyperfractionated radiation therapy on Radiation Therapy Oncology Group Protocol 8313K K Fu, J D Cox, T F Pajak, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1995
Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomasD J Lee, D Cosmatos, V A Marcial, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610A Pollack, D J Grignon, K H Heydon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2023
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099M Al-Sarraf, M LeBlanc, P G Giri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099M Al-Sarraf, M LeBlanc, P G Giri, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.
Journal of the National Cancer Institute|January 15, 1997
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610D J Grignon, R Caplan, F H Sarkar, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Head and Neck Cancer CommitteeK Ang, R Weber, E Vokes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trialF R Khuri, E S Kim, J J Lee, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Cancer|June 1, 1992
Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol 8313J D Cox, T F Pajak, V A Marcial, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1994
Carcinomas of the oropharynx treated with hyperfractionated radiation therapy on Radiation Therapy Oncology Group Protocol 8313K K Fu, J D Cox, T F Pajak, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1995
Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomasD J Lee, D Cosmatos, V A Marcial, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610A Pollack, D J Grignon, K H Heydon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2023
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099M Al-Sarraf, M LeBlanc, P G Giri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099M Al-Sarraf, M LeBlanc, P G Giri, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.
Journal of the National Cancer Institute|January 15, 1997
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610D J Grignon, R Caplan, F H Sarkar, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Head and Neck Cancer CommitteeK Ang, R Weber, E Vokes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trialF R Khuri, E S Kim, J J Lee, et al.
Pageof 11